Regulators should stay out of choosing what types of publicly traded investments are right for market participants.
Public investments should be available to all market participants, not those deemed "worthy" by regulators.
No one should have to take a test in order to trade a leveraged or inverse ETF.
Leveraged and inverse funds are important for portfolio strategy, particularly for those investors who are already limited by qualified plans.
Please allocate your time to regulating things that really harm retail investors, for example: payment for order flow data, mispriced and overhyped IPOs, crypto funds, etc.
Adam Coleman Comment On Regulatory Notice 22-08
Regulators should stay out of choosing what types of publicly traded investments are right for market participants.
Public investments should be available to all market participants, not those deemed "worthy" by regulators.
No one should have to take a test in order to trade a leveraged or inverse ETF.
Leveraged and inverse funds are important for portfolio strategy, particularly for those investors who are already limited by qualified plans.
Please allocate your time to regulating things that really harm retail investors, for example: payment for order flow data, mispriced and overhyped IPOs, crypto funds, etc.